Showing results (451-460 of 641) with videos related to
Sort By:
Pageof 65
Stem Cell Reports|July 8, 2022
Human liver organoids for disease modeling of fibrolamellar carcinomaNicole J C Narayan, David Requena, Gadi Lalazar, et al.Cell|April 30, 2019
Insulin/IGF-1 Drives PERIOD Synthesis to Entrain Circadian Rhythms with Feeding TimePriya Crosby, Ryan Hamnett, Marrit Putker, et al.The Journal of Pathology|March 29, 2024
Polyketide synthase positive Escherichia coli one-time measurement in stool is not informative of colorectal cancer risk in a screening settingWillemijn de Klaver, Meike de Wit, Anne Bolijn, et al.Cancer Letters|December 28, 2020
SIRT1 inhibitors mitigate radiation-induced GI syndrome by enhancing intestinal-stem-cell survivalGuoxiang Fu, Shengzhi Chen, Liping Liang, et al.Nature Communications|October 1, 2014
A20 controls intestinal homeostasis through cell-specific activitiesLars Vereecke, Sara Vieira-Silva, Thomas Billiet, et al.Cell|June 29, 2019
Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast CancerHua Wang, Dongxi Xiang, Ben Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|April 7, 2004
Illegitimate WNT signaling promotes proliferation of multiple myeloma cellsPatrick W B Derksen, Esther Tjin, Helen P Meijer, et al.Science (New York, N.Y.)|May 19, 2018
Notch ligand Dll1 mediates cross-talk between mammary stem cells and the macrophageal nicheRumela Chakrabarti, Toni Celià-Terrassa, Sushil Kumar, et al.Nature|October 2, 2024
Tuft cells act as regenerative stem cells in the human intestineLulu Huang, Jochem H Bernink, Amir Giladi, et al.Cell Reports|March 31, 2023
Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancerSander Mertens, Maarten A Huismans, Carla S Verissimo, et al.Pageof 65